Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2013
Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbsBertrand Allard, Sandra Pommey, Mark J Smyth, et al.Oncoimmunology|July 29, 2016
CD73-adenosine reduces immune responses and survival in ovarian cancer patientsPierre-Olivier Gaudreau, Bertrand Allard, Martin Turcotte, et al.Immunological Reviews|March 5, 2017
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targetsBertrand Allard, Maria Serena Longhi, Simon C Robson, et al.Immunology Letters|May 15, 2018
Targeting the CD73-adenosine axis in immuno-oncologyDavid Allard, Pavel Chrobak, Bertrand Allard, et al.Current Opinion in Pharmacology|May 23, 2016
Immunosuppressive activities of adenosine in cancerBertrand Allard, Paul A Beavis, Phillip K Darcy, et al.Immunotherapy|January 26, 2016
CD73-adenosine: a next-generation target in immuno-oncologyDavid Allard, Bertrand Allard, Pierre-Olivier Gaudreau, et al.International Journal of Cancer|August 29, 2013
Anti-CD73 therapy impairs tumor angiogenesisBertrand Allard, Martin Turcotte, Kathleen Spring, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
CD73 plays a protective role in collagen-induced arthritisPavel Chrobak, Roxanne Charlebois, Pavel Rejtar, et al.Oncoimmunology|August 16, 2019
Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasisBertrand Allard, Isabelle Cousineau, David Allard, et al.DNA and Cell Biology|June 22, 2011
Electroporation-aided DNA immunization generates polyclonal antibodies against the native conformation of human endothelin B receptorBertrand Allard, Fabienne Priam, Frédérique Deshayes, et al.Pageof 4